Cargando…
Safety for the environment of a feed additive consisting of nicarbazin (Coxar(®)) for use in turkeys for fattening (Huvepharma N.V.)
Following a request from the European Commission, the Panel on Additives and Products or substances used in Animal Feed (FEEDAP Panel) was asked to deliver a scientific opinion on the safety for the environment of the coccidiostat Coxar(®) (nicarbazin) when used in feed for turkeys for fattening. In...
Autores principales: | Bampidis, Vasileios, Bastos, Maria de Lourdes, Christensen, Henrik, Dusemund, Birgit, Fašmon Durjava, Mojca, Kouba, Maryline, López‐Alonso, Marta, López Puente, Secundino, Marcon, Francesca, Mayo, Baltasar, Pechová, Alena, Petkova, Mariana, Ramos, Fernando, Sanz, Yolanda, Villa, Roberto Edoardo, Woutersen, Ruud, Finizio, Antonio, Focks, Andreas, Teodorovic, Ivana, Vettori, Maria Vittoria, Azimonti, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319813/ https://www.ncbi.nlm.nih.gov/pubmed/34354768 http://dx.doi.org/10.2903/j.efsa.2021.6715 |
Ejemplares similares
-
Efficacy of a feed additive consisting of nicarbazin (Coxar(®)) for use in turkeys for fattening (Huvepharma N.V.)
por: Bampidis, Vasileios, et al.
Publicado: (2022) -
Safety and efficacy of Coxar(®) (nicarbazin) for turkeys for fattening
por: Rychen, Guido, et al.
Publicado: (2018) -
Safety for the environment of Monimax(®) (monensin sodium and nicarbazin) for chickens for fattening, chickens reared for laying and for turkeys for fattening
por: Bampidis, Vasileios, et al.
Publicado: (2019) -
Safety and efficacy of a feed additive consisting of halofuginone hydrobromide (STENOROL®) for chickens for fattening and turkeys for fattening/reared for breeding (Huvepharma N.V.)
por: Bampidis, Vasileios, et al.
Publicado: (2023) -
Safety of a feed additive consisting of halofuginone hydrobromide (STENOROL®) for chickens for fattening and turkeys (Huvepharma N.V.)
por: Bampidis, Vasileios, et al.
Publicado: (2022)